HER3 overexpression has been associated with poor outcome in many cancer types.36,37 In our 51 TNBC samples, 82.4% displayed negative or weak HER3 expression by IHC, and all tested samples had less than 5500 receptors per cell by TR-FRET analysis. This evidence concerns the gene ERBB3 and cancer.